Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmabinoid is a leading European contract development and manufacturing organization (CDMO) specializing in cannabinoid-based products for the pharmaceutical, nutraceutical, and cosmetic industries. Based in the Netherlands, the company provides a full suite of services including raw material sourcing, custom formulation, and GMP-compliant manufacturing of oils, isolates, and finished dosage forms. Their product portfolio features a wide range of cannabinoids such as CBD, CBG, and CBN, as well as specialized minor cannabinoids and nano-emulsified solutions. Pharmabinoid supports global clients through private label services and bulk ingredient supply, ensuring high purity and regulatory compliance. The company's expertise in extraction and purification technologies positions it as a key partner for businesses looking to integrate cannabinoid science into their product lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmabinoid.